The project and core leaders have 23-30 years of coordinated and collaborative research in the field of study (sphingolipids in cancer biology and therapy). Moreover, the group continues to coordinate jointly the strategic development of the research questions as well as address specific research issues. Indeed, a highly coordinated group has emerged comprised of approximately 30 investigators, students, and postdoctoral fellows from the 4 primary laboratories and 2 Shared Resources. The group shares contiguous or adjacent laboratory space at Stony Brook University Cancer Center with many common equipment in a set up that allows fostering of the individual identities of each lab while encouraging collaboration and sharing. The entire group meets weekly, and program leadership meets monthly. Consequently, this group has acquired a highly advanced team spirit with focus on studying sphingolipids in cancer biology and therapeutics. The group has a high level of joint publications (in all permutations that also involve the core leaders). Core A, the Administrative Shared Resource, will continue to provide seamless integration at the operational level for the component projects and research shared resources of this Program. Thus, the core will assist in the overall administration and financial accountability of the Program Project, the overall leadership, the promotion of the goals of the program, and arranging the required meetings for the various program-related groups and committees including the internal and external advisory committees. We have now 14+ years of proof of the efficacy of this Core, as no issues have emerged regarding budgeting, meetings, conflicts in core use, or other possible sources of friction or discontent.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA097132-16
Application #
9793240
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-09-01
Budget End
2020-08-31
Support Year
16
Fiscal Year
2019
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Xu, Ruijuan; Garcia-Barros, Monica; Wen, Sally et al. (2018) Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2. Cell Death Differ 25:841-856
Coant, Nicolas; Hannun, Yusuf A (2018) Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer. Adv Biol Regul :
Trayssac, Magali; Hannun, Yusuf A; Obeid, Lina M (2018) Role of sphingolipids in senescence: implication in aging and age-related diseases. J Clin Invest 128:2702-2712
Munshi, Mansa A; Gardin, Justin M; Singh, Ashutosh et al. (2018) The Role of Ceramide Synthases in the Pathogenicity of Cryptococcus neoformans. Cell Rep 22:1392-1400
Snider, Justin M; Snider, Ashley J; Obeid, Lina M et al. (2018) Probing de novo sphingolipid metabolism in mammalian cells utilizing mass spectrometry. J Lipid Res 59:1046-1057
Li, Fang; Xu, Ruijuan; Low, Benjamin E et al. (2018) Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates. FASEB J 32:3058-3069
Pulkoski-Gross, Michael J; Jenkins, Meredith L; Truman, Jean-Philip et al. (2018) An intrinsic lipid-binding interface controls sphingosine kinase 1 function. J Lipid Res 59:462-474
Williams, Bianca; Correnti, Jason; Oranu, Amanke et al. (2018) A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. FASEB J 32:130-142
Bai, Aiping; Bielawska, Alicja; Rahmaniyan, Mehrdad et al. (2018) Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites. Bioorg Med Chem 26:6067-6075
Newcomb, Benjamin; Rhein, Cosima; Mileva, Izolda et al. (2018) Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5. J Lipid Res 59:1219-1229

Showing the most recent 10 out of 215 publications